Security Snapshot

AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) Institutional Ownership

CUSIP: 023436108

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

1

Shares (Excl. Options)

1

Price

$101.00

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 3 signals
Share change
0
Number of holders
1
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
32,982,385
SEC-reported price per share
$101.00
Insider filing price
$101.00
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • AMED - AMEDISYS INC - Common Stock, par value $0.001 per share is tracked under CUSIP 023436108.
  • 1 institution reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1 to 1 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $101 to $101.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 1 institution filings for Q1 2026.

Open SEC evidence

Security key

023436108

Latest holder period

Q1 2026

13F holders

1

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
AMED
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GOLDMAN SACHS GROUP INC 0% -108% $19,188 -$178,680,496 190 -100% THE GOLDMAN SACHS GROUP, INC. 30 Sep 2025

As of 31 Mar 2026, 1 institutional investors reported holding 1 shares of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED). This represents 0% of the company’s total 32,982,385 outstanding shares.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1 $101 $101.00 1
2025 Q4 1 $101 -$57,453 $101.00 1
2025 Q3 582 $57,554 -$3,198,236,425 $99.79 4
2025 Q2 32,988,261 $3,245,032,619 +$158,439,809 $98.39 318
2025 Q1 31,712,364 $2,937,637,500 -$44,225,875 $92.63 302
2024 Q4 32,072,548 $2,911,289,403 +$45,469,084 $90.79 289
2024 Q3 31,104,840 $3,001,877,264 +$5,995,463 $96.51 282
2024 Q2 31,067,678 $2,853,693,997 +$79,318,831 $91.80 287
2024 Q1 30,596,920 $2,819,745,626 -$78,638,381 $92.16 280
2023 Q4 31,505,475 $2,994,445,626 +$158,414,857 $95.06 285
2023 Q3 29,904,687 $2,793,414,584 -$4,373,774 $93.40 284
2023 Q2 29,980,075 $2,740,518,682 -$71,288,435 $91.44 297
2023 Q1 31,250,815 $2,298,987,210 +$6,757,528 $73.55 276
2022 Q4 31,107,723 $2,599,215,989 -$51,467,952 $83.54 271
2022 Q3 31,547,667 $3,053,632,701 +$111,680,523 $96.79 268
2022 Q2 29,252,616 $3,079,861,282 -$83,631,487 $105.12 271
2022 Q1 30,205,611 $5,201,601,524 +$176,038,628 $172.29 317
2021 Q4 29,255,269 $4,733,452,345 +$74,262,561 $161.88 314
2021 Q3 28,284,976 $4,217,606,134 -$207,742,696 $149.10 340
2021 Q2 28,923,326 $7,084,910,657 +$78,583,021 $244.93 362
2021 Q1 28,502,858 $7,549,005,908 -$67,770,886 $264.79 382
2020 Q4 29,105,018 $8,536,392,508 +$83,416,142 $293.33 392
2020 Q3 28,914,071 $6,828,800,828 -$191,408,695 $236.43 384
2020 Q2 29,715,664 $5,899,715,526 +$146,681,226 $198.54 343
2020 Q1 29,014,408 $5,322,433,405 +$4,554,348 $183.54 323
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .